TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 220,201 | 193,879 | 165,527 |
Financial expenses | 1,650 | 945 | 625 |
Earnings before taxes | 13,776 | 10,178 | 8,995 |
EBITDA | 20,675 | 16,487 | 13,311 |
Total assets | 197,385 | 171,123 | 151,188 |
Current assets | 90,856 | 70,853 | 62,885 |
Current liabilities | 53,316 | 32,160 | 28,110 |
Equity capital | 104,102 | 95,218 | 88,442 |
- share capital | 500 | 500 | 500 |
Employees (average) | 76 | 76 | 74 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 52.7% | 55.6% | 58.5% |
Turnover per employee | 2,897 | 2,551 | 2,237 |
Profit as a percentage of turnover | 6.3% | 5.2% | 5.4% |
Return on assets (ROA) | 7.8% | 6.5% | 6.4% |
Current ratio | 170.4% | 220.3% | 223.7% |
Return on equity (ROE) | 13.2% | 10.7% | 10.2% |
Change turnover | 26,322 | 28,352 | -48,520 |
Change turnover % | 14% | 17% | -23% |
Chg. No. of employees | 0 | 2 | 1 |
Chg. No. of employees % | 0% | 3% | 1% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.